39816-19-8

Usage

Uses

Used in Organic Synthesis:
4-Styrylpyridazine serves as a valuable building block in organic synthesis, utilized for the creation of new molecules with distinct properties. Its styryl group is particularly reactive, allowing for a range of chemical reactions to be performed, which is beneficial for the development of novel compounds.
Used in Materials Science:
In the field of materials science, 4-styrylpyridazine is explored for its potential to contribute to the development of new materials. Its unique structure and reactivity can be harnessed to engineer materials with specific characteristics required for various applications.
Used in Pharmaceutical Research:
4-Styrylpyridazine holds promise in pharmaceutical research, where it can be employed as a starting point for the design and synthesis of new drugs. Its chemical versatility aids in the exploration of different drug candidates with potential therapeutic effects.
Used in Optoelectronics:
4 STYRYLPYRIDAZINE has potential applications in optoelectronics, where its electronic and optical properties can be exploited in the development of devices such as light-emitting diodes, solar cells, and photodetectors.
Used as a Fluorescent Probe in Biological Research:
4-Styrylpyridazine can be utilized as a fluorescent probe in biological research, where its optical properties allow for the tracking and visualization of biological processes at the molecular level, contributing to a better understanding of cellular mechanisms and interactions.

InChI:InChI=1/C12H10N2/c1-2-4-11(5-3-1)6-7-12-8-9-13-14-10-12/h1-10H

Upstream product

• 1120-88-3 4-methylpyridazine 
• 100-52-7 benzaldehyde 

Downstream Products

• 50901-43-4 4-hydroxymethylpyridazine 
• 50901-42-3 pyridazine-4-carbaldehyde 

Relevant academic research and scientific papers

BENZIMIDAZOLE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to compounds of formula (I); compositions comprising the compounds, and methods of using the compounds to treat or prevent pain, diabetes, a diabetic complication, impaired glucose tolerance (IGT) or impaired fasting glucose

Pyrazolopyrimidinones which inhibit type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterase (cGMP PDE5) for the treatment of sexual dysfunction

Compounds of formulae (IA) and (IB) or pharmaceutically or veterinarily acceptable salts thereof, or pharmaceutically or veterinarily acceptable solvates of either entity, wherein R1 is C1 to C3 alkyl substituted with C3 to C6 cycloalkyl, CONR5R6 or a N-linked heterocyclic group; (CH2)nHet or (CH2)nAr; R2 is C1 to C6 alkyl; R3 is C1 to C6 alkyl optionally substituted with C1 to C4 alkoxy; R4 is SO2NR7R8; R5 and R6 are each independently selected from H and C1 to C4 alkyl optionally substituted with C1 to C4 alkoxy, or, together with the nitrogen atom to which they are attached, form a 5- or 6-membered heterocyclic group; R7 and R8, together with the nitrogen atom to which they are attached, form a 4-R10-piperazinyl group; R10 is H or C1 to C4 alkyl optionally substituted with OH, C1 to C4 alkoxy or CONH2; H is an optionally substituted C-linked 5- or 6-membered heterocyclic group; Ar is optionally substituted phenyl; and n is 0 or 1; are potent and selective cGMP PDE5 inhibitors useful in the treatment of, inter alia, male erectile dysfunction and female sexual dysfunction.

INDOLE DERIVATIVES USEFUL AS HISTAMINE H3 ANTAGONISTS

Disclosed are novel compounds of the formula I wherein M1 is CH or N and M2 is C(R3) or N; R1 is optionally substituted indolyl or an aza derivative thereof; R2 is optionally substituted aryl or heteroaryl; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of Formula I. Also disclosed are methods of treating various diseases or conditions, such as, for example, allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion) using the compounds of formula I in combination with a H1 receptor antagonist.